SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition
Selenium-binding protein 1 (SELENBP1) is frequently dysregulated in various malignancies including colorectal cancer (CRC); however, its roles in progression of CRCs and the underlying mechanism remain to be elucidated. In this study, we compared the expression of SELENBP1 between CRCs and colorecta...
Main Authors: | Zhang Xiaotian, Hong Runqi, Bei Lanxin, Hu Zhiqing, Yang Ximin, Song Tao, Chen Liang, Meng He, Niu Gengming, Ke Chongwei |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2022-09-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2022-0532 |
Similar Items
-
Selenium binding protein 1 inhibits tumor angiogenesis in colorectal cancers by blocking the Delta-like ligand 4/Notch1 signaling pathway
by: Xiaotian Zhang, et al.
Published: (2022-04-01) -
UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer
by: Ping Cui, et al.
Published: (2022-09-01) -
GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial–mesenchymal transition of hepatic stellate cells
by: Niu Gengming, et al.
Published: (2021-09-01) -
MiR-1-3p Suppresses Colorectal Cancer Cell Proliferation and Metastasis by Inhibiting YWHAZ-Mediated Epithelial–Mesenchymal Transition
by: Guanghong Du, et al.
Published: (2021-02-01) -
Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer
by: Lloyd ePereira, et al.
Published: (2015-02-01)